Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMC Entertainment Holdings
AMC
|
+$36.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$16.5M |
| 3 |
McDonald's
MCD
|
+$14.5M |
| 4 |
Sinclair Inc
SBGI
|
+$12.6M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Independence Realty Trust
IRT
|
+$8.78M |
| 2 |
AbbVie
ABBV
|
+$8.19M |
| 3 |
Visa
V
|
+$8.05M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$7.33M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.78% |
| 2 | Technology | 13.29% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Axogen
AXGN
$2.71B
| $1.25M | 0.13% |
120,000
| – | – |
|
|
DO
227
DELISTED
Diamond Offshore Drilling
DO
| $1.25M | 0.13% |
+75,000
| New | +$1.27M |
|
228
Nice
NICE
$5.87B
| $1.25M | 0.13% |
+18,360
| New | +$1.26M |
|
229
Flowserve
FLS
$10.1B
| $1.25M | 0.12% |
+25,718
| New | +$1.25M |
|
230
NorthWestern Energy
NWE
$4.27B
| $1.23M | 0.12% |
+20,968
| New | +$1.2M |
|
231
Aramark
ARMK
$15.8B
| $1.22M | 0.12% |
+45,684
| New | +$1.16M |
|
232
Universal Health Services
UHS
$10.4B
| $1.21M | 0.12% |
9,719
+7,753
| +394% | +$916K |
|
233
NCR Voyix
VYX
$1.09B
| $1.2M | 0.12% |
+42,771
| New | +$1.17M |
|
234
Gray Television
GTN
$509M
| $1.19M | 0.12% |
82,026
+56,036
| +216% | +$709K |
|
235
SPS Commerce
SPSC
$2.92B
| $1.18M | 0.12% |
+40,172
| New | +$1.23M |
|
236
e.l.f. Beauty
ELF
$6.02B
| $1.17M | 0.12% |
+40,575
| New | +$1.1M |
|
237
Fidelity National Information Services
FIS
$21.3B
| $1.17M | 0.12% |
14,671
+11,844
| +419% | +$953K |
|
238
East-West Bancorp
EWBC
$17.8B
| $1.15M | 0.12% |
+22,237
| New | +$1.17M |
|
|
CDK
239
DELISTED
CDK Global, Inc.
CDK
| $1.14M | 0.11% |
+17,551
| New | +$1.12M |
|
240
Zions Bancorporation
ZION
$9.95B
| $1.13M | 0.11% |
+26,848
| New | +$1.17M |
|
241
Green Dot
GDOT
$766M
| $1.12M | 0.11% |
+33,691
| New | +$954K |
|
242
Corcept Therapeutics
CORT
$13.2B
| $1.1M | 0.11% |
100,005
-198,984
| -67% | -$1.75M |
|
243
Broadcom
AVGO
$1.75T
| $1.09M | 0.11% |
49,790
-62,410
| -56% | -$1.29M |
|
244
CME Group
CME
$98.9B
| $1.08M | 0.11% |
9,089
+3,886
| +75% | +$467K |
|
|
PPL
245
PPL Corp
PPL
$25.9B
| $1.08M | 0.11% |
+28,811
| New | +$1.03M |
|
246
Jazz Pharmaceuticals
JAZZ
$16.5B
| $1.07M | 0.11% |
+7,402
| New | +$964K |
|
247
PG&E
PCG
$38.8B
| $1.06M | 0.11% |
16,031
+2,926
| +22% | +$187K |
|
|
CNCE
248
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.05M | 0.11% |
61,831
-28,169
| -31% | -$338K |
|
|
RP
249
DELISTED
RealPage, Inc.
RP
| $1.05M | 0.11% |
30,001
+1
| +0% | +$33 |
|
250
Halliburton
HAL
$29.4B
| $1.04M | 0.1% |
+21,194
| New | +$1.14M |
|
Similar funds
Steve Schonfeld's Q1 2017 Portfolio in Review
As of Q1 2017, Steve Schonfeld held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.
- Steve Schonfeld's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
- Steve Schonfeld added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
- Steve Schonfeld's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
- Steve Schonfeld fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
- Steve Schonfeld's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
- Steve Schonfeld opened 316 new positions and closed 270 in Q1 2017.
- Steve Schonfeld's portfolio value rose 29% quarter-over-quarter to $998M.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.